Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

16.90
Delayed Data
As of 4:00pm ET
 +0.55 / +3.36%
Today’s Change
11.85
Today|||52-Week Range
19.25
+21.15%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 18.00 and a low estimate of 10.00. The median estimate represents a -5.33% decrease from the last price of 16.90.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.01
Sales
$66.6M
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 102.67%
 
 
 
 
 
 
Growthannually -284.49%
 
 
 
 
 
 

Sales

Growthquarterly 176.40%
 
 
 
 
 
 
Growthannually 29.65%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.